Similarly, in patients with well-controlled T2DM, the administration of CCK at a physiological dose (0.4 pmol/kg/min) was shown to slow gastric emptying and reduce postprandial blood glucose excursions [102]. This evidence concerns the gene CCK and type 2 diabetes mellitus.